Prediction Markets Are Betting Against Rocket Lab: Here’s What the Odds Say

Prediction markets are flashing warning signs for Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction), even as Wall Street analysts remain overwhelmingly bullish on the space company. Polymarket traders are pricing in continued downside for the stock, which has cratered 35.6% over the past month and is down 18.4% in just the last week. But here is the catch: these markets are thin, and the crowd has a poor track record on this ticker.

Polymarket Is Screaming “Below $70” for July

The most active Polymarket contract asks what price Rocket Lab will hit during July 2026. With Rocket Lab trading at $67.35, the odds are stacked toward the downside:

• $64 target: 88% implied probability
• $60 target: 64.5% implied probability
• $108 target: 5.2% implied probability
• $112 target: 2.1% implied probability

The message from bettors is stark: they are giving low-single-digit odds to any recovery back toward the triple digits this month, while pricing in a high probability the stock dips further into the low $60s. Total volume on that July market is just $9,836.60, with open interest of $3,450.93. Thin, but directionally consistent.

Daily Direction Bets Are Also Bearish

Polymarket’s recurring “RKLB Daily Up or Down” series showed a 43.5% probability that Rocket Lab would close higher on July 16, 2026. The stock ultimately fell 11.6% that session, closing at $67.35 from an open near $76.20. That single-day drop essentially validated the bearish tilt, though the market resolved with a last trade at 0.15 on the “Up” contract.

The Crowd’s Track Record on the Stock Is Poor

Here is why traders should treat these odds as a sentiment gauge, not a forecast. Across 21 resolved RKLB prediction markets on Polymarket, the crowd has been correct only 28.6% of the time. That is worse than a coin flip on binary-style outcomes.

The pattern that emerges is systematic underestimation. Recent examples where the crowd got it wrong on the low side:

• June 2026 monthly market: crowd implied $109.14, actual $132 (miss of −$22.86)
• May 2026 monthly market: crowd implied $85.59, actual $104 (miss of −$62.41)
• April 2026 monthly market: crowd implied $40.00, actual $92 (miss of −$52.00)
• Week of May 18, 2026: crowd implied $111.06, actual $136 (miss of −$24.94)

That history matters. If the crowd has repeatedly underestimated Rocket Lab’s price potential, today’s bearish clustering below $70 could turn out to be another anchoring miss, or it could finally be right after a brutal drawdown.

Analysts and Bettors Are on Opposite Sides

Wall Street’s take stands in sharp contrast to the Polymarket crowd. The analyst consensus price target is $116.57, implying 73.1% upside from current levels. The sentiment remains positive, though it has moderated somewhat since May.

Meanwhile, insiders have logged 91 recent transactions with a net selling direction, adding a wrinkle to the bull thesis. The composite prediction sentiment score is 57.88 (neutral, medium confidence), with a 30-day change of −14.86 points.

Fundamentals Conflict With the Odds

The bearish odds sit uncomfortably against Rocket Lab’s operational momentum. Q1 FY2026 delivered record revenue of $200.35 million, up 63.5% year over year, beating consensus by 5.77%. EPS came in at −$0.07, ahead of the −$0.079 estimate. Backlog reached $2.20 billion, up 20.2% sequentially, and non-GAAP gross margin expanded to 43.0% from 33.4% a year earlier.

CEO Peter Beck framed the quarter this way:

Rocket Lab has delivered another exceptional quarter with record financial performance of more than $200 million in revenue. … We exited the quarter with $2.2 billion in backlog and currently have access to more than $2 billion in liquidity, putting us in a very strong position for continued growth and M&A execution.

Guidance for Q2 2026 calls for revenue of $225 million to $240 million and non-GAAP gross margins of 38% to 40%. The Neutron medium-lift rocket remains on track for a debut launch later in 2026, though it slipped from a prior Q1 2026 target after a stage-1 tank test failure.

Why the Downside Bets Right Now?

Three overlapping factors explain the bearish Polymarket positioning:

1. Price action: RKLB is down 37.6% from June 17 through July 16, and traders anchor to recent moves.
2. Sector fatigue: A late June Reddit thread titled “So did we stop caring about Space now?” drew 461 upvotes and 395 comments, capturing the mood.
3. Execution overhang: The Neutron delay and heavy stock-based compensation ($28.1 million in Q1 2026) continue to weigh on sentiment.

The Reddit sentiment window, however, tells a more nuanced story. Following the June 29, 2026, Iridium acquisition announcement, sentiment scores spiked into the 66 to 76 bullish range, with one post titled “Rocket Lab to Acquire Iridium in Historic Deal, Creating A Fully Vertically Integrated Space Powerhouse Primed for Growth” drawing 370 upvotes. By mid-July, the mood cooled again as another widely engaged thread asked why “Rocket Lab and AST SpaceMobile are both down 40%+ from their May highs.”

Volume, Liquidity, and the Grain of Salt

Any read of these odds needs context on liquidity. The July 2026 monthly market has traded roughly $9,836.60 in total volume. The Week of July 13 market has traded about $9,213.16. These are sentiment thermometers, with thin liquidity rather than deep, institutional-grade order books.

Contrast that with November 2025’s monthly hit-price event, which cleared 485,798.73 USDC in total volume, with the $108 upside target alone capturing 346,617 USDC. That event ultimately saw every upside target from $68 to $108 resolved YES, and every downside target from $26 to $64 also resolved YES, reflecting the extreme volatility that has defined the ticker.

What to Watch Next

Rocket Lab’s Q2 2026 earnings report is the next major catalyst, along with any updated timeline on Neutron’s Q4 debut launch. The gap between Polymarket’s bearish cluster below $70 and the $116.57 analyst consensus gives investors a wide range of outcomes to consider: bettors are anchored to the recent drawdown, while sell-side models still price in Neutron’s commercial ramp and the $816 million SDA Tranche 3 contract.

The one-year return is still 41.2%, and the five-year return at 523.6%. Prediction markets are calling for more pain in the near term. History says the crowd has been wrong on the stock more often than right. Keep an eye on shares into the next earnings cycle.

Contact [email protected] for any questions or corrections.